The Sage Group Client Delcath Announces Commercial Licensing Agreement for CHEMOSAT®The Sage Group Client Delcath Announces Commercial Licensing Agreement for CHEMOSAT® 7 Year Agreement with medac to Maximize Potential of...
Opportunity to Partner OncoSec: a Novel Immunotherapy Company10 December 2018 - New York and London - The Sage Group is pleased to announce that it is working with OncoSec, an American corporation,...